Fatal Case of COVID-19-Associated Acute Hemorrhagic Leukoencephalitis Without Respiratory Involvement: A Diagnostic and Therapeutic Challenge.

Fatal Case of COVID-19-Associated Acute Hemorrhagic Leukoencephalitis Without Respiratory Involvement: A Diagnostic and Therapeutic Challenge.

Publication date: Aug 01, 2025

We report a rare and fatal case of acute hemorrhagic leukoencephalitis (AHLE) as the sole manifestation of COVID-19 in a 76-year-old woman who presented without respiratory symptoms. The patient was admitted with an acute altered mental status following a recent fall and a positive SARS-CoV-2 test. Initial imaging showed a small subdural hematoma; however, further evaluation revealed widespread white matter changes and petechial hemorrhages on MRI, consistent with AHLE. Despite aggressive treatment, including intravenous immunoglobulin (IVIG) and high-dose corticosteroids, the patient showed minimal neurological recovery. Cerebrospinal fluid (CSF) studies revealed elevated protein with no infectious or autoimmune markers, and the brain biopsy was non-contributory. She was ultimately transitioned to hospice care. This case underscores the importance of considering AHLE in COVID-19 patients presenting with isolated neurological deterioration, even in the absence of pulmonary involvement. Prompt recognition and escalation of care are crucial, although the prognosis remains poor.

Open Access PDF

Concepts Keywords
Aggressive covid-19
Covid general internal medicine
Hematoma infectious disease medicine
Old intravenous immunoglobulins (ivig)
Woman

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Acute Hemorrhagic Leukoencephalitis
disease MESH subdural hematoma
disease MESH hemorrhages
drug DRUGBANK Immune Globulin Human
disease IDO protein
pathway REACTOME Reproduction
disease MESH acute disseminated encephalomyelitis
disease MESH syndromes
disease MESH inflammation
disease MESH demyelination
disease MESH complications
disease MESH viral infections
disease MESH encephalopathy
disease MESH multiple sclerosis
disease IDO history
disease MESH hypertension
disease MESH hyperlipidemia
disease MESH transient ischemic attack
disease MESH emergency
disease IDO facility
disease MESH Coma
disease MESH anisocoria
disease MESH stroke
disease IDO blood
disease MESH respiratory alkalosis
drug DRUGBANK Sulodexide
disease MESH vertebral artery stenosis
disease MESH dissociation
drug DRUGBANK Potassium
drug DRUGBANK Creatinine
drug DRUGBANK Calcium
drug DRUGBANK Ammonia
disease MESH infectious disease
pathway REACTOME Infectious disease

Original Article

(Visited 7 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *